Interparfums Earnings Call Transcripts
Fiscal Year 2026
-
Sales grew 2% to $345M with strong U.S. and Latin America performance, while Europe and Asia faced headwinds. Gross margin expanded to 65.1%, and net income rose 2% to $43M. Full-year guidance is unchanged, with new brand launches and innovation expected to drive growth in 2027.
Fiscal Year 2025
-
Record 2025 sales of $1.49B were driven by strong brand launches and digital expansion, despite tariff and FX headwinds. Guidance for 2026 remains steady amid market volatility, with major innovation expected in 2027.
-
Q3 sales rose 1% year-over-year, with strong performance from key brands and digital channels, but gross margin declined due to tariffs. Full-year 2025 guidance calls for modest growth, with stronger gains expected in 2027 from new brand launches and innovation.
-
Organic net sales grew 3% in H1, with strong European performance offsetting U.S. declines due to the Dunhill exit. Gross margin expanded, and 2025 guidance for $1.51B in sales and $5.35 EPS was reaffirmed, with e-commerce and new launches expected to drive H2 growth.
-
Net sales grew 5% year-over-year to $339 million, with strong gross margin expansion and operating income up 10%. Guidance for 2025 is reaffirmed at $1.51 billion in sales and $5.35 EPS, with tariff and FX risks being actively managed. Luxury and premium segments continue to outperform.
Fiscal Year 2024
-
Record 2024 sales and earnings exceeded guidance, driven by strong brand launches and global growth. 2025 guidance targets 4% growth amid FX and regulatory headwinds, with major innovation and blockbuster launches planned. Dividend increased 7% to $3.20 per share.
-
Record Q3 sales and margins were driven by strong global demand, digital marketing, and new launches. Guidance for 2024 is reaffirmed with upper single-digit Q4 growth expected, while inventory and receivables remain well-managed.
-
Record Q2 sales and profitability were driven by strong brand launches, expanded celebrity partnerships, and robust growth in key markets. Guidance for 2024 was reaffirmed, with continued investment in innovation and a proprietary luxury fragrance line set for 2025.